Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.medmal.2016.05.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Imagine, Discover, Inspire: Proceedings of the 4th International Conference of the Trisomy 21 Research Society.
Neuromolecular Med
January 2025
Department of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, USA.
Down syndrome (DS) or trisomy 21 (T21) is present in a significant number of children and adults around the world and is associated with cognitive and medical challenges. Through research, the T21 Research Society (T21RS), established in 2014, unites a worldwide community dedicated to understanding the impact of T21 on biological systems and improving the quality of life of people with DS across the lifespan. T21RS hosts an international conference every two years to support collaboration, dissemination, and information sharing for this goal.
View Article and Find Full Text PDFProceedings of the Clinical Microbiology Open 2023: discussions about pandemic preparedness.
J Clin Microbiol
June 2024
Department of Pathology, Virginia Commonwealth University Health System, Richmond, Virginia, USA.
Article Synopsis
- - The 4th Clinical Microbiology Open (CMO) was held on February 10-11, 2023, in Carlsbad, California, bringing together lab directors, government agencies, and industry leaders to discuss key public health issues.
- - The main focus of the discussions was on pandemic preparedness, addressing crucial questions related to testing, potential future pathogens, necessary research, and the role of self-testing.
- - The document provides a summary of the conversations held during the event, emphasizing insights gained regarding responses to pandemics and their implications for future laboratory practices.
Combined Metronomic Chemo-immunotherapy (CMCI) in Head and Neck Cancers-An Experience from a Developing Country.
Indian J Surg Oncol
June 2024
Department of Radiation Oncology, J N Medical College, Belagavi, Karnataka India.
Head and neck squamous cell carcinomas (HNSCC) have proven to be inherently resistant to systemic treatments as a result of histological, molecular, and etiological heterogeneity, with limited responses seen after second-line therapy and beyond. With limited treatment options after progression on systemic chemotherapy in HNSCCs, immunotherapy has a role to play with improved results. In this prospective, observational, non-randomized, open-label study, a total of 12 patients with advanced, relapsed, or metastatic HNSCC received Inj.
View Article and Find Full Text PDFStretching the Scope of Behavioral Interventions: Proceedings of the 4th International Behavioural Trials Network Hybrid Meeting.
Ann Behav Med
April 2024
Department of Health, Kinesiology, and Applied Physiology, Concordia University, Montreal, Canada.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!